primary liver cancer
Conditions
Interventions
Sponsors
Shuguang Hospial Affiliated to Shanghai University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) patients with primary liver cancer after radical resection (BCLC stage 0, stage A); (2) patients within 3 months after surgical treatment (surgery, radiofrequency ablation); (3) aged 18 to 65 years, gender is not limited; (4) willing to accept Chinese medicine and/or integrated Chinese and western medicine treatment; (5) sign informed consent.
Exclusion criteria
Exclusion criteria: (1) metastatic liver cancer patients, or concurrent with other cancer patients; (2) Without radical surgery or with refractory ascites, hepatic encephalopathy, liver failure, portal vein embolism and other serious complications; (3) accompanied by heart, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract serious primary disease; Or mentally ill; (4) legally disabled persons, pregnant women or nursing women; (5) allergy or multiple drug allergy patients; (6) patients with molecular targeted anti-tumor drugs (sorafenib).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrence rate;Survival period; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatality rate;Intestinal flora;Child-pugh grading;MRI;liver function;AFP;Quality of Life Scale; | — |
Countries
China
Contacts
Public ContactXuehua Sun
Shuguang Hospital affiliated to Shanghai Universtiy of Traditonal Chinese Medicine
Outcome results
None listed